Home » Topics » Disease categories and therapies » Infection

Infection
RSS

New antibiotic from Sankyo

Nov. 1, 1996

Cefzil approved for new indication in U.S.

Nov. 1, 1996

Expanded indications for Abelcet

Oct. 25, 1996

Seventeenth approval for Amphocil/Amphotec

Oct. 25, 1996

Key patents issued covering Applied Microbiology's lanthocins

Oct. 25, 1996

Natural antibacterial chitinase inhibitors

Oct. 25, 1996

New cephalosporin derivatives from Roche

Oct. 25, 1996

Albendazole introduced in the U.S. for two parasitic infections

Oct. 18, 1996

Glaxo Wellcome claims antiviral agents with RNA virus specificity

Oct. 18, 1996

RiboGene receives grant for antiviral compounds based on PKR

Oct. 18, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...